The performance of United Therapeutics Corp (UTHR) Stock has improved
Morgan Stanley raised the price target for the United Therapeutics Corp (NASDAQ:UTHR) stock from “an Overweight” to “an Equal-weight”. The rating was released on July 11, 2024, according to finviz. We previously noted in another research note published on February 12, 2024 by Goldman that upgraded the stock from a Sell to a Neutral with […]
United Therapeutics Corp (UTHR) Stock: Amazing technical data that you never knew existed
Morgan Stanley raised the price target for the United Therapeutics Corp (NASDAQ:UTHR) stock from “an Overweight” to “an Equal-weight”. The rating was released on July 11, 2024, according to finviz. We previously noted in another research note published on February 12, 2024 by Goldman that upgraded the stock from a Sell to a Neutral with […]
Risks and Returns of United Therapeutics Corp (UTHR) Stock
Morgan Stanley raised the price target for the United Therapeutics Corp (NASDAQ:UTHR) stock from “an Overweight” to “an Equal-weight”. The rating was released on July 11, 2024, according to finviz. We previously noted in another research note published on February 12, 2024 by Goldman that upgraded the stock from a Sell to a Neutral with […]
Would United Therapeutics Corp (UTHR) Stock like to attract the attention of traders?
Morgan Stanley raised the price target for the United Therapeutics Corp (NASDAQ:UTHR) stock from “an Overweight” to “an Equal-weight”. The rating was released on Jul-12-24, according to finviz. We previously noted in another research note published on February 12, 2024 by Goldman that upgraded the stock from a Sell to a Neutral with a price […]
A leader in the success game: United Therapeutics Corp (UTHR) Stock
Goldman raised the price target for the United Therapeutics Corp (NASDAQ:UTHR) stock from “a Sell” to “a Neutral”. The rating was released on February 12, 2024, according to finviz. The research report from Wells Fargo has initiated the stock to Overweight, with a price target set at $309. The stock was initiated by UBS, who […]
United Therapeutics Corp (NASDAQ:UTHR) Stock higher 45.05% in This Year: What’s Happened?
Goldman raised the price target for the United Therapeutics Corp (NASDAQ:UTHR) stock from “a Sell” to “a Neutral”. The rating was released on February 12, 2024, according to finviz. The research report from Wells Fargo has initiated the stock to Overweight, with a price target set at $309. The stock was initiated by UBS, who […]
